SM
MRNA icon

Stephen Mandel’s Moderna MRNA Stock Holding History

Stephen Mandel’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,529,618
Closed -$186M – 29
2023
Q2 		$186M Hold
1,529,618
– – 1.7% 25
2023
Q1 		$235M Buy
1,529,618
+177,100
+13% +$29.2M 2.17% 22
2022
Q4 		$243M Buy
+1,352,518
New +$221M 2.32% 18
2021
Q4 		– Sell
-3,316,199
Closed -$1.28B – 38
2021
Q3 		$1.28B Sell
3,316,199
-674,698
-17% -$249M 4.3% 9
2021
Q2 		$938M Buy
+3,990,897
New +$713M 3.02% 16

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Stephen Mandel's MRNA Position: Q3 2023 in Review

Stephen Mandel sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,529,618 shares — an estimated $186M sold.

Stephen Mandel first reported a position in MRNA in Q2 2021 and held it in 5 quarters. The position peaked at $1.28B in Q3 2021. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Stephen Mandel reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Stephen Mandel sold 1,529,618 Moderna shares in Q3 2023, an estimated $186M.
  • Stephen Mandel first reported a position in Moderna in Q2 2021 and held it in 5 quarters.
  • Stephen Mandel's Moderna position peaked at $1.28B in Q3 2021.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Lone Pine Capital's 13F filing for Q3 2023, filed 14 Nov 2023.